How Does Fructose Intake Contribute to Obesity?

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -
  • More than 40% of adults in the United States have obesity, of whom almost 10% have severe obesity.
  • Obesity is a risk factor for many health conditions, including cardiovascular diseases, type 2 diabetes, and some cancers.
  • The fundamental cause of obesity is an energy imbalance between calories consumed and calories expended.
  • However, it may not be just the amount of calories, but the source of those calories that can lead to obesity. 
  • New research suggests that fructose — a simple sugar found in many foods — may drive obesity and related health conditions.

According to the World Health Organization (WHO)Trusted Source, some 13% of adults worldwide have obesity. Although obesity rates are increasing in low-income countries, most are in higher-income countries.

Follow the link below to read the full article on Medical News Today

https://www.medicalnewstoday.com/articles/how-does-fructose-intake-contribute-to-obesity?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-08-07&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -